and biconvex clinical trials

SGL-TX-PTDM: SGLT2i effect on PTDM development and kidney allograft function in kidney transplant recipients: A randomized, double-blind, placebo controlled, national multicenter trial

This study looks at how a drug called Forxiga affects new diabetes and kidney health in people who've had a kidney transplant. It compares Forxiga to a dummy pill to see if it makes a difference over 6 to 12 months.